vs

Side-by-side financial comparison of Idaho Strategic Resources, Inc. (IDR) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

IRIDEX CORP is the larger business by last-quarter revenue ($14.7M vs $14.6M, roughly 1.0× Idaho Strategic Resources, Inc.). On growth, Idaho Strategic Resources, Inc. posted the faster year-over-year revenue change (92.0% vs -69.7%). Over the past eight quarters, Idaho Strategic Resources, Inc.'s revenue compounded faster (57.2% CAGR vs 11.9%).

Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

IDR vs IRIX — Head-to-Head

Bigger by revenue
IRIX
IRIX
1.0× larger
IRIX
$14.7M
$14.6M
IDR
Growing faster (revenue YoY)
IDR
IDR
+161.8% gap
IDR
92.0%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IDR
IDR
Annualised
IDR
57.2%
11.9%
IRIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IDR
IDR
IRIX
IRIX
Revenue
$14.6M
$14.7M
Net Profit
$9.4M
Gross Margin
68.5%
37.2%
Operating Margin
62.4%
Net Margin
64.3%
Revenue YoY
92.0%
-69.7%
Net Profit YoY
220.6%
EPS (diluted)
$0.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IDR
IDR
IRIX
IRIX
Q4 25
$14.6M
$14.7M
Q3 25
$11.1M
$12.5M
Q2 25
$9.5M
$13.6M
Q1 25
$7.3M
$11.9M
Q4 24
$7.6M
$12.7M
Q3 24
$6.2M
$11.6M
Q2 24
$6.1M
$12.6M
Q1 24
$5.9M
$11.8M
Net Profit
IDR
IDR
IRIX
IRIX
Q4 25
$9.4M
Q3 25
$3.0M
$-1.6M
Q2 25
$2.8M
$-994.0K
Q1 25
$1.6M
$-1.7M
Q4 24
$2.9M
$-834.0K
Q3 24
$1.6M
$-1.9M
Q2 24
$2.2M
$-2.7M
Q1 24
$2.2M
$-3.5M
Gross Margin
IDR
IDR
IRIX
IRIX
Q4 25
68.5%
37.2%
Q3 25
63.6%
32.1%
Q2 25
57.8%
34.5%
Q1 25
50.8%
42.5%
Q4 24
53.3%
44.0%
Q3 24
48.7%
37.3%
Q2 24
50.2%
40.7%
Q1 24
48.1%
37.9%
Operating Margin
IDR
IDR
IRIX
IRIX
Q4 25
62.4%
Q3 25
23.4%
-11.3%
Q2 25
26.6%
-6.9%
Q1 25
19.3%
-1.7%
Q4 24
36.2%
-3.9%
Q3 24
23.4%
-16.1%
Q2 24
34.2%
-20.9%
Q1 24
36.3%
-28.0%
Net Margin
IDR
IDR
IRIX
IRIX
Q4 25
64.3%
Q3 25
26.8%
-12.6%
Q2 25
29.2%
-7.3%
Q1 25
22.1%
-14.2%
Q4 24
38.5%
-6.6%
Q3 24
25.8%
-16.7%
Q2 24
35.2%
-21.2%
Q1 24
36.8%
-29.5%
EPS (diluted)
IDR
IDR
IRIX
IRIX
Q4 25
$0.62
Q3 25
$0.20
$-0.09
Q2 25
$0.20
$-0.06
Q1 25
$0.12
$-0.10
Q4 24
$0.21
$-0.05
Q3 24
$0.12
$-0.12
Q2 24
$0.17
$-0.16
Q1 24
$0.17
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IDR
IDR
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$6.0M
Total DebtLower is stronger
$2.3M
Stockholders' EquityBook value
$108.2M
Total Assets
$116.2M
$29.2M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IDR
IDR
IRIX
IRIX
Q4 25
$6.0M
Q3 25
$5.6M
Q2 25
$6.8M
Q1 25
$7.2M
Q4 24
$2.4M
Q3 24
$3.9M
Q2 24
$6.3M
$4.1M
Q1 24
$5.3M
$5.4M
Total Debt
IDR
IDR
IRIX
IRIX
Q4 25
$2.3M
Q3 25
$3.0M
Q2 25
$3.3M
Q1 25
$3.7M
Q4 24
$1.7M
$1.0M
Q3 24
$2.9M
$1.4M
Q2 24
$2.7M
Q1 24
$3.3M
Stockholders' Equity
IDR
IDR
IRIX
IRIX
Q4 25
$108.2M
Q3 25
$74.3M
$4.7M
Q2 25
$49.3M
$6.1M
Q1 25
$39.8M
$852.0K
Q4 24
$37.7M
$2.1M
Q3 24
$33.1M
$2.6M
Q2 24
$25.4M
$4.2M
Q1 24
$21.6M
$6.5M
Total Assets
IDR
IDR
IRIX
IRIX
Q4 25
$116.2M
$29.2M
Q3 25
$83.1M
$28.4M
Q2 25
$57.7M
$31.6M
Q1 25
$48.1M
$34.2M
Q4 24
$44.0M
$29.1M
Q3 24
$40.8M
$30.2M
Q2 24
$32.2M
$31.2M
Q1 24
$28.7M
$34.1M
Debt / Equity
IDR
IDR
IRIX
IRIX
Q4 25
0.02×
Q3 25
0.04×
Q2 25
0.07×
Q1 25
0.09×
Q4 24
0.05×
0.48×
Q3 24
0.09×
0.53×
Q2 24
0.11×
Q1 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IDR
IDR
IRIX
IRIX
Operating Cash FlowLast quarter
$10.7M
Free Cash FlowOCF − Capex
$8.2M
FCF MarginFCF / Revenue
56.0%
Capex IntensityCapex / Revenue
17.7%
Cash ConversionOCF / Net Profit
1.15×
TTM Free Cash FlowTrailing 4 quarters
$12.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IDR
IDR
IRIX
IRIX
Q4 25
$10.7M
Q3 25
$2.4M
$-1.2M
Q2 25
$3.5M
$-397.0K
Q1 25
$2.4M
$-1.1M
Q4 24
$3.2M
$-1.2M
Q3 24
$2.5M
$-3.1M
Q2 24
$2.6M
$-1.3M
Q1 24
$2.6M
$-1.6M
Free Cash Flow
IDR
IDR
IRIX
IRIX
Q4 25
$8.2M
Q3 25
$709.8K
$-1.2M
Q2 25
$2.5M
$-410.0K
Q1 25
$1.0M
$-1.2M
Q4 24
$2.1M
$-1.2M
Q3 24
$1.9M
$-3.1M
Q2 24
$2.4M
Q1 24
$2.3M
$-1.7M
FCF Margin
IDR
IDR
IRIX
IRIX
Q4 25
56.0%
Q3 25
6.4%
-9.4%
Q2 25
26.5%
-3.0%
Q1 25
13.8%
-9.8%
Q4 24
28.0%
-9.8%
Q3 24
30.4%
-26.5%
Q2 24
38.7%
Q1 24
38.3%
-14.0%
Capex Intensity
IDR
IDR
IRIX
IRIX
Q4 25
17.7%
Q3 25
15.3%
0.1%
Q2 25
10.8%
0.1%
Q1 25
19.4%
0.1%
Q4 24
13.6%
0.1%
Q3 24
9.8%
0.0%
Q2 24
4.3%
0.0%
Q1 24
5.5%
0.0%
Cash Conversion
IDR
IDR
IRIX
IRIX
Q4 25
1.15×
Q3 25
0.81×
Q2 25
1.28×
Q1 25
1.50×
Q4 24
1.08×
Q3 24
1.56×
Q2 24
1.22×
Q1 24
1.19×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons